The presence of the epidermal growth factor receptor (EGFR) gene mutation is associated with a high rate of distant metastasis and poor prognosis in patients with non-small cell lung cancer (NSCLC). EGFR signaling acts as mediator of bone metastasis by increasing tumor cell proliferation and promotes synthesis and secretion of numerous angiogenic growth factors. We propose that metastatic bone lesions with and without the EGFR mutation in primary NSCLC have different perfusion profiles and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) parameters can reveal the differences.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords